Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B0c4ac7842fac486f37f7760b8f58d874> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B0c4ac7842fac486f37f7760b8f58d874 NCIT_P378 "NCI" @default.
- B0c4ac7842fac486f37f7760b8f58d874 type Axiom @default.
- B0c4ac7842fac486f37f7760b8f58d874 annotatedProperty IAO_0000115 @default.
- B0c4ac7842fac486f37f7760b8f58d874 annotatedSource NCIT_C2600 @default.
- B0c4ac7842fac486f37f7760b8f58d874 annotatedTarget "A synthetic radioimmunoconjugate comprised of a humanized anti-interleukin-2 (IL-2) antibody linked to the radioisotope Yttrium 90 with potential antineoplastic activity. Daclizumab binds with high affinity to the Tac (also called CD25) subunit of the IL-2 receptor complex and inhibits the binding of IL-2, thereby blocking the IL-2-mediated activation of lymphocytes. As Yttrium Y 90 daclizumab, daclizumab delivers radiation specifically to lymphocytes that express the IL-2 receptor. (NCI04)" @default.